Drug profile

The FDA adverse-event record for Bov.Virus*3/M Haem/Past Mult

49 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bov.Virus*3/M Haem/Past Mult. See the species affected, top reactions, and outcomes below.

49
adverse-event reports
87.8%
death-coded share
Cattle
most-reported species
40
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
49
Total Reports
43
Deaths Reported
87.8%
Death Rate

Active Ingredients

Bov.Virus*3/M Haem/Past Mult

Administration Routes

NasalUnknownSubcutaneous

Species Affected

Cattle 49

Most Affected Breeds

Cattle (other) 30
Crossbred Bovine/Cattle 8
Holstein-Friesian also known as Holstein 3
Brangus 2
Aberdeen Angus 2
Cattle (unspecified) 1
Simmental 1
Hereford cattle 1
Highland 1

Most Reported Reactions

Death 40
Lack of efficacy - NOS 27
Lack of efficacy (bacteria) - NOS 11
Necropsy performed 6
Death by euthanasia 3
Found dead 3
Lack of efficacy (virus) - coronavirus - NOS 2
Lack of efficacy (virus) - coronavirus (Infectious Bronchitis Virus) 2
Distress 1
Pain NOS 1
Respiratory distress 1
Neck writhing 1

Outcome Breakdown

Died
43 (42.2%)
Ongoing
21 (20.6%)
Recovered/Normal
20 (19.6%)
Outcome Unknown
14 (13.7%)
Euthanized
4 (3.9%)

Bov.Virus*3/M Haem/Past Mult Adverse Event Insights

49 reports name Bov.Virus*3/M Haem/Past Mult; 43 recorded a death outcome (87.8% of reported events, not a population-level mortality rate). Active ingredient: Bov.Virus*3/M Haem/Past Mult. Administration routes: Nasal, Unknown, Subcutaneous.

By species: Cattle (49 reports). By breed: Cattle (other) (30), Crossbred Bovine/Cattle (8), Holstein-Friesian also known as Holstein (3).

Leading clinical signs: Death (40), Lack of efficacy - NOS (27), Lack of efficacy (bacteria) - NOS (11), Necropsy performed (6). Outcome, 102 coded reports: Died leads at 42.2%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.